Olympus Biotech has launched its new contract manufacturing offering at its facility in Lebanon, NH. “The increasing number of monoclonal antibodies and recombinant proteins in the market and in development has fueled a need for experienced, sophisticated manufacturing partners that can support preclinical through commercial production,” said Peter Gariepy, vice president, operations.  “Our highly skilled team, history of successful alliances and strategic flexibility position Olympus as a partn...